• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度东部社会经济阶层较低和较高地区革兰氏阴性菌对碳青霉烯类抗生素耐药率的差异

Differing Rates of Carbapenem Resistance in Gram-Negative Bacteria Within Lower and Higher Socioeconomic Classes in Eastern India.

作者信息

Chakraborty Debarghya, Roy Triparna, Gangopadhyay Priyankar

机构信息

Internal Medicine, Princess Royal University Hospital, London, GBR.

Biostatistics and Health Informatics, King's College London, London, GBR.

出版信息

Cureus. 2025 May 7;17(5):e83661. doi: 10.7759/cureus.83661. eCollection 2025 May.

DOI:10.7759/cureus.83661
PMID:40486325
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12143861/
Abstract

Background Over the last 50 years, medical science has witnessed the emergence of antibacterial resistance at a concerning rate. Southeast Asia has become a leading epicenter for the development and spread of carbapenem-resistant bacterial strains. Socioeconomic background, being a major health determinant, can heavily affect this rate of antibiotic resistance.  Methods This retrospective study was conducted at a 1,700-bed tertiary care facility in Kolkata, India, between October 2023 and January 2024. A total of 248 culture results from urine, sputum, blood, wound, and ascitic fluid, which showed growth of Gram-negative bacilli (GNB) and coccobacilli (GNCB) during the study period, were analyzed. Medical records were reviewed to collect demographic and clinical data. The comparison was made between two population groups based on economic status, identified by ration cards as defined by the Government of West Bengal, India.  Results This study assessed the prevalence and antibiotic resistance patterns of Gram-negative bacteria in clinical samples, focusing on urine, blood, sputum, wound, and ascitic fluid. The analysis revealed that GNB were widely distributed across sample types, while GNCB showed higher prevalence in blood and ascitic fluid. Antibiotic resistance was notably prevalent among GNB, with 49 (27.5%) resistant to imipenem and 50 (28.1%) to meropenem. GNCB exhibited lower resistance, with six (14.3%) resistant to imipenem, eight (19.0%) to meropenem, and seven (16.7%) to doripenem. A comparison of carbapenem resistance (CR) between higher and lower socioeconomic classes showed no statistically significant differences, with resistance rates of 15 (41.7%) and 96 (45.3%), respectively. Further analysis of the most common isolates (, , , and ) also revealed no significant correlation between socioeconomic status and resistance, emphasizing that antibiotic resistance is a widespread issue transcending economic boundaries.  Conclusion This study examines CR in Gram-negative bacteria across socioeconomic groups in Eastern India, finding no significant differences in resistance between higher and lower economic classes. Both groups showed similar levels of resistance, highlighting that antibiotic misuse, overprescription, and inadequate stewardship are pervasive issues transcending economic boundaries. The study emphasizes the need for enhanced healthcare provider training, public education on antibiotic misuse, and policy interventions to improve sanitation and waste management. Effective antibiotic stewardship and public health measures are crucial for combating resistance and ensuring equitable health outcomes.

摘要

背景 在过去50年里,医学见证了抗菌耐药性以令人担忧的速度出现。东南亚已成为耐碳青霉烯类细菌菌株产生和传播的主要中心。社会经济背景作为一个主要的健康决定因素,会严重影响抗生素耐药率。

方法 这项回顾性研究于2023年10月至2024年1月在印度加尔各答一家拥有1700张床位的三级医疗机构进行。对研究期间来自尿液、痰液、血液、伤口和腹水的248份培养结果进行了分析,这些结果显示有革兰氏阴性杆菌(GNB)和球杆菌(GNCB)生长。查阅医疗记录以收集人口统计学和临床数据。根据印度西孟加拉邦政府定义的配给卡确定经济状况,对两个人口群体进行比较。

结果 本研究评估了临床样本中革兰氏阴性菌的流行情况和抗生素耐药模式,重点关注尿液、血液、痰液、伤口和腹水。分析显示,GNB广泛分布于各种样本类型中,而GNCB在血液和腹水中的患病率较高。GNB中抗生素耐药现象尤为普遍,49株(27.5%)对亚胺培南耐药,50株(28.1%)对美罗培南耐药。GNCB的耐药性较低,6株(14.3%)对亚胺培南耐药,8株(19.0%)对美罗培南耐药,7株(16.7%)对多立培南耐药。对社会经济阶层较高和较低的人群之间的碳青霉烯类耐药性(CR)进行比较,结果显示无统计学显著差异,耐药率分别为15株(41.7%)和96株(45.3%)。对最常见分离株( 、 、 和 )的进一步分析也显示社会经济地位与耐药性之间无显著相关性,强调抗生素耐药是一个跨越经济界限的普遍问题。

结论 本研究调查了印度东部不同社会经济群体中革兰氏阴性菌的CR情况,发现社会经济阶层较高和较低的人群之间在耐药性方面无显著差异。两组的耐药水平相似,这突出表明抗生素滥用、过度处方和管理不善是跨越经济界限的普遍问题。该研究强调需要加强医护人员培训、开展关于抗生素滥用的公众教育以及采取政策干预措施以改善卫生和废物管理。有效的抗生素管理和公共卫生措施对于对抗耐药性和确保公平的健康结果至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf6/12143861/195b02bc94ac/cureus-0017-00000083661-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf6/12143861/3d5ff2e14bc3/cureus-0017-00000083661-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf6/12143861/dfa598d294af/cureus-0017-00000083661-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf6/12143861/4bd36276ef85/cureus-0017-00000083661-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf6/12143861/3323a3d67a66/cureus-0017-00000083661-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf6/12143861/195b02bc94ac/cureus-0017-00000083661-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf6/12143861/3d5ff2e14bc3/cureus-0017-00000083661-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf6/12143861/dfa598d294af/cureus-0017-00000083661-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf6/12143861/4bd36276ef85/cureus-0017-00000083661-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf6/12143861/3323a3d67a66/cureus-0017-00000083661-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf6/12143861/195b02bc94ac/cureus-0017-00000083661-i05.jpg

相似文献

1
Differing Rates of Carbapenem Resistance in Gram-Negative Bacteria Within Lower and Higher Socioeconomic Classes in Eastern India.印度东部社会经济阶层较低和较高地区革兰氏阴性菌对碳青霉烯类抗生素耐药率的差异
Cureus. 2025 May 7;17(5):e83661. doi: 10.7759/cureus.83661. eCollection 2025 May.
2
Antibiotic Resistance Trends in Carbapenem-Resistant Gram-Negative Pathogens and Eight-Year Surveillance of XDR Bloodstream Infections in a Western Greece Tertiary Hospital.希腊西部一家三级医院碳青霉烯耐药革兰阴性病原菌的抗生素耐药性趋势及广泛耐药血流感染的八年监测
Pathogens. 2024 Dec 23;13(12):1136. doi: 10.3390/pathogens13121136.
3
Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit.肯尼亚重症监护病房耐碳青霉烯类革兰氏阴性菌感染及获得的危险因素。
BMC Infect Dis. 2024 May 23;24(1):522. doi: 10.1186/s12879-024-09256-6.
4
Prevalence of Carbapenem Non-susceptible Gram-Negative Bacteria at Tertiary Care Hospitals in Saudi Arabia.沙特阿拉伯三级医疗医院中碳青霉烯类不敏感革兰氏阴性菌的患病率。
Cureus. 2023 Jan 14;15(1):e33767. doi: 10.7759/cureus.33767. eCollection 2023 Jan.
5
[Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].抗菌药物管理计划对多重耐药革兰阴性菌抗菌药物使用及检出率的影响
Zhonghua Er Ke Za Zhi. 2019 Jul 2;57(7):553-558. doi: 10.3760/cma.j.issn.0578-1310.2019.07.012.
6
First report of carbapenems encoding multidrug-resistant gram-negative bacteria from a pediatric hospital in Gaza Strip, Palestine.来自加沙地带巴勒斯坦儿科医院的碳青霉烯类抗生素编码多重耐药革兰氏阴性菌的首次报告。
BMC Microbiol. 2024 Oct 9;24(1):393. doi: 10.1186/s12866-024-03550-8.
7
The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies.联合治疗在治疗碳青霉烯类耐药革兰氏阴性菌引起的严重感染中的作用:临床研究的系统评价。
BMC Infect Dis. 2021 Jun 9;21(1):545. doi: 10.1186/s12879-021-06253-x.
8
Nationwide surveillance of carbapenem-resistant Gram-negative pathogens in the Lebanese environment.黎巴嫩环境中耐碳青霉烯革兰氏阴性病原体的全国性监测。
Appl Environ Microbiol. 2025 Jul 23;91(7):e0193224. doi: 10.1128/aem.01932-24. Epub 2025 Jun 10.
9
Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.基于 2014 年中国 153 家三级医院的数据,探讨抗生素使用与碳青霉烯类耐药革兰氏阴性菌发生率之间的关系。
Antimicrob Resist Infect Control. 2018 Nov 19;7:137. doi: 10.1186/s13756-018-0430-1. eCollection 2018.
10
Epidemiology and clinical characteristics of patients with healthcare-acquired multidrug-resistant Gram-negative bacilli: a retrospective study from a tertiary care hospital.医疗机构获得性多重耐药革兰氏阴性杆菌感染患者的流行病学和临床特征:来自一家三级医院的回顾性研究。
Sci Rep. 2024 Feb 6;14(1):3022. doi: 10.1038/s41598-024-53596-x.

本文引用的文献

1
Knowledge, attitudes and practices of antimicrobial resistance awareness among healthcare workers in India: a systematic review.印度医护人员对抗微生物药物耐药性认知的知识、态度和实践:系统评价。
Front Public Health. 2024 Jul 22;12:1433430. doi: 10.3389/fpubh.2024.1433430. eCollection 2024.
2
Response to antimicrobial resistance in South-East Asia Region.东南亚地区对抗菌素耐药性的应对措施。
Lancet Reg Health Southeast Asia. 2023 Oct 29;18:100306. doi: 10.1016/j.lansea.2023.100306. eCollection 2023 Nov.
3
Trends in carbapenem resistance in Pre-COVID and COVID times in a tertiary care hospital in North India.
印度北部一家三级医院在新冠疫情前和疫情期间碳青霉烯类耐药趋势。
Ann Clin Microbiol Antimicrob. 2023 Jan 3;22(1):1. doi: 10.1186/s12941-022-00549-9.
4
The crisis of carbapenemase-mediated carbapenem resistance across the human-animal-environmental interface in India.印度人类-动物-环境界面中碳青霉烯酶介导的碳青霉烯类耐药性的危机。
Infect Dis Now. 2023 Feb;53(1):104628. doi: 10.1016/j.idnow.2022.09.023. Epub 2022 Oct 12.
5
Genome-wide identification of carbapenem-resistant Gram-negative bacterial (CR-GNB) isolates retrieved from hospitalized patients in Bihar, India.从印度比哈尔邦住院患者中分离的耐碳青霉烯类革兰氏阴性菌(CR-GNB)的全基因组鉴定。
Sci Rep. 2022 May 19;12(1):8477. doi: 10.1038/s41598-022-12471-3.
6
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
7
High-Resolution Genomic Profiling of Carbapenem-Resistant Klebsiella pneumoniae Isolates: A Multicentric Retrospective Indian Study.碳青霉烯类耐药肺炎克雷伯菌的高分辨率基因组分析:一项多中心回顾性印度研究。
Clin Infect Dis. 2021 Dec 1;73(Suppl_4):S300-S307. doi: 10.1093/cid/ciab767.
8
Risk factors for antibiotic resistance development in healthcare settings in China: a systematic review.中国医疗机构抗生素耐药性发展的危险因素:系统评价。
Epidemiol Infect. 2021 Jun 3;149:e141. doi: 10.1017/S0950268821001254.
9
Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019.2019 年在欧洲、亚洲和拉丁美洲收集的肠杆菌科临床分离株的阿佐巴坦/阿维巴坦活性。
J Antimicrob Chemother. 2021 Feb 11;76(3):659-666. doi: 10.1093/jac/dkaa504.
10
Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli.产 ESBL 大肠埃希菌中外源氟苯尼考耐药导致对碳青霉烯类药物的体外交叉耐药。
Int J Antimicrob Agents. 2020 Mar;55(3):105902. doi: 10.1016/j.ijantimicag.2020.105902. Epub 2020 Jan 17.